Hypoxia-regulated tumor-derived exosomes and tumor progression: a focus on immune evasion

X Shao, S Hua, T Feng, DKW Ocansey… - International journal of …, 2022 - mdpi.com
Tumor cells express a high quantity of exosomes packaged with unique cargos under
hypoxia, an important characteristic feature in solid tumors. These hypoxic tumor-derived …

Instigation of the epoch of nanovaccines in cancer immunotherapy

S Shah, P Famta, V Tiwari, AK Kotha… - Wiley …, 2023 - Wiley Online Library
Cancer is an unprecedented proliferation of cells leading to abnormalities in differentiation
and maturation. Treatment of primary and metastatic cancer is challenging. In addition to …

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

P Czajka-Francuz, MJ Prendes, A Mankan… - Frontiers in …, 2023 - frontiersin.org
The efficacy of cancer therapies is limited to a great extent by immunosuppressive
mechanisms within the tumor microenvironment (TME). Numerous immune escape …

FUCA2 is a prognostic biomarker and correlated with an immunosuppressive microenvironment in pan-cancer

A Zhong, T Chen, Y Xing, X Pan, M Shi - Frontiers in immunology, 2021 - frontiersin.org
Background The expression of Fucosidase, alpha-L-2 (FUCA2) varies across tumors.
However, its role in various tumor types and relationship with the tumor immune …

Mucosal associated invariant T cells in cancer-friend or foe?

C O'Neill, FC Cassidy, D O'Shea, AE Hogan - Cancers, 2021 - mdpi.com
Simple Summary Mucosal associated invariant T (MAIT) cells are a population of innate T
cells which play an important role in host protection against bacterial, fungi and viruses …

[HTML][HTML] Antibody-drug conjugates: beyond current approvals and potential future strategies

S Menon, S Parakh, AM Scott… - Exploration of targeted anti …, 2022 - ncbi.nlm.nih.gov
The recent approvals for antibody-drug conjugates (ADCs) in multiple malignancies in
recent years have fuelled the ongoing development of this class of drugs. These novel …

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer

G Wu, M Chen, H Ren, X Sha, M He, K Ren… - Frontiers in Cell and …, 2022 - frontiersin.org
Background: Adaptor-related protein complex 3, sigma one subunit (AP3S1) is one of the
encoding subunits of the adaptor complex AP-3. However, its role in various tumor types and …

[HTML][HTML] A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors

Y Li, W Fu, Z Geng, Y Song, X Yang, T He, J Wu… - PeerJ, 2022 - peerj.com
Background Recent studies have identified ribonucleotide reductase subunit M2 (RRM2) as
a putative promoter of tumors. However, no systematic analysis of its carcinogenicity has …

Identification of hub genes in colorectal adenocarcinoma by integrated bioinformatics

Y Liu, L Chen, X Meng, S Ye, L Ma - Frontiers in Cell and …, 2022 - frontiersin.org
An improved understanding of the molecular mechanism of colorectal adenocarcinoma is
necessary to predict the prognosis and develop new target gene therapy strategies. This …

SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer

Y Huang, M You, Q Wu, W Zhu… - Annals of Clinical & …, 2022 - Assoc Clin Scientists
Objective Shc SH2 domain-binding protein (SHCBP1) is involved in regulating tumour
progression in a variety of tumour types. The aim of this study was to analyze the prognostic …